Re: Dugel et al: HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration (Ophthalmology. 2019 Apr 12 [Epub ahead of print]) / Sharma, A.; Kumar, N.; Bandello, F.. - In: OPHTHALMOLOGY. - ISSN 0161-6420. - 126:12(2019), pp. e95-e96. [Epub ahead of print] [10.1016/j.ophtha.2019.08.017]

Re: Dugel et al: HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration (Ophthalmology. 2019 Apr 12 [Epub ahead of print])

Bandello F.
2019-01-01

2019
Animals
Antibodies, Monoclonal, Humanized
Visual Acuity
Hawks
Macular Degeneration
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/108305
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact